United Therapeutics Corporation

BMV:UTHR * Stock Report

Market Cap: Mex$328.7b

United Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BMV:UTHR * Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Dec 24SellMex$84,617,018Louis SullivanIndividual11,209Mex$7,709.69
11 Nov 24SellMex$14,754,337Judy OlianIndividual1,750Mex$8,431.05
08 Nov 24SellMex$1,857,072Nilda MesaIndividual224Mex$8,290.50
01 Nov 24SellMex$3,854,745Christopher CauseyIndividual510Mex$7,558.32
03 Sep 24SellMex$8,038,839James EdgemondIndividual1,119Mex$7,183.95
26 Aug 24SellMex$7,626,533James EdgemondIndividual1,133Mex$6,731.27
19 Aug 24SellMex$7,159,768James EdgemondIndividual1,162Mex$6,161.59
25 Jun 24SellMex$1,535,938Nilda MesaIndividual266Mex$5,774.20
17 Jun 24SellMex$9,303,776Judy OlianIndividual1,700Mex$5,472.81
27 Mar 24SellMex$1,277,057Nilda MesaIndividual325Mex$3,929.41
23 Feb 24SellMex$6,446,098Christopher PatuskyIndividual1,680Mex$3,836.96

Insider Trading Volume

Insider Buying: UTHR * insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of UTHR *?
Owner TypeNumber of SharesOwnership Percentage
State or Government59,2270.131%
Individual Insiders791,8601.75%
Hedge Funds2,858,8886.31%
Institutions41,574,51291.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 70.1% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.9%
BlackRock, Inc.
5,317,397Mex$39.2b-2.77%0.03%
9.88%
The Vanguard Group, Inc.
4,409,610Mex$32.5b-0.21%0.02%
7.1%
Wellington Management Group LLP
3,170,849Mex$23.3b-3.48%0.18%
6.4%
Avoro Capital Advisors LLC
2,858,888Mex$21.1b0%14.41%
5.01%
State Street Global Advisors, Inc.
2,238,224Mex$16.5b-2.44%0.03%
4.83%
Renaissance Technologies LLC
2,155,392Mex$15.9b-0.89%1.12%
2.45%
Geode Capital Management, LLC
1,094,015Mex$8.1b4.35%0.03%
2.38%
FMR LLC
1,060,364Mex$7.8b41.6%0.02%
2.17%
LSV Asset Management
969,465Mex$7.1b0.32%0.68%
2.14%
AQR Capital Management, LLC
956,631Mex$7.0b33.3%0.46%
1.49%
Martine Rothblatt
666,822Mex$4.9b3.03%no data
1.44%
Arrowstreet Capital, Limited Partnership
641,599Mex$4.7b46.3%0.18%
1.39%
Dimensional Fund Advisors LP
621,032Mex$4.6b5.98%0.03%
1.27%
Fuller & Thaler Asset Management, Inc.
568,392Mex$4.2b-1.15%0.81%
1.27%
Pacer Advisors, Inc.
566,703Mex$4.2b0.87%0.46%
1.24%
AllianceBernstein L.P.
551,680Mex$4.1b2.24%0.06%
1.03%
Janus Henderson Group plc
460,419Mex$3.4b12.3%0.07%
0.94%
AssetMark, Inc.
419,957Mex$3.1b56.9%0.43%
0.93%
Swedbank Robur Fonder AB
414,937Mex$3.1b-1.83%0.1%
0.88%
BNY Asset Management
393,446Mex$2.9b-7.74%0.03%
0.85%
Northern Trust Global Investments
378,556Mex$2.8b4.36%0.02%
0.83%
Charles Schwab Investment Management, Inc.
369,955Mex$2.7b-4.6%0.02%
0.77%
T. Rowe Price Group, Inc.
344,527Mex$2.5b46.7%0.01%
0.77%
Caisse de dépôt et placement du Québec
343,744Mex$2.5b32.5%0.12%
0.72%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
321,987Mex$2.4b-15.4%0.03%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 03:48
End of Day Share Price 2024/10/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

United Therapeutics Corporation is covered by 37 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
James BirchenoughBarclays
Derek TallerBenchmark Company